(Q39231169)
Statements
Beneficial effect of cabergoline, new long-lasting D2 agonist in the treatment of Parkinson's disease (English)
A D Korczyn
2 references
J M Rabey
P Nissipeanu
scientific article published on June 1994
No description defined